Phase II Trial of Consolidative Thoracic Radiotherapy for Extensive Stage Small Cell Lung Cancer
Interventional
Primary Purpose: Treatment
local control
we anticipate completing accrual to the study in 12 months with most local failure events occuring within 2 years of treatment
Don Yee, MD, FRCPC
Principal Investigator
Alberta Health Services
Canada: Health Canada
LU-23929/23929
NCT00643396
February 2008
January 2012
Name | Location |
---|